{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:12:40Z","timestamp":1793394760793,"version":"4.5.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamadermatol.2021.3459","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T11:03:22Z","timestamp":1631703802000},"page":"1289","source":"Crossref","is-referenced-by-count":146,"title":["Sirolimus (Rapamycin) for Slow-Flow Malformations in Children"],"prefix":"10.1001","volume":"157","author":[{"given":"Annabel","family":"Maruani","sequence":"first","affiliation":[{"name":"University of Tours, University of Nantes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, SPHERE U1246, Tours, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Tours), Tours, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale Clinical Investigation Center 1415, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Tavernier","sequence":"additional","affiliation":[{"name":"University of Tours, University of Nantes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, SPHERE U1246, Tours, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale Clinical Investigation Center 1415, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Boccara","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Necker), University Hospital Necker-Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leducq","sequence":"additional","affiliation":[{"name":"University of Tours, University of Nantes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, SPHERE U1246, Tours, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Tours), Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bessis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guibaud","sequence":"additional","affiliation":[{"name":"University Hospital Center of Lyon, Consultation Multidisciplinaire Lyonnaise des Angiomes, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vabres","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Carmignac","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Mallet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chiaverini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Droitcourt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Bursztejn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Nancy, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lengell\u00e9","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Clinical Pharmacology, Regional Pharmacovigilance Center, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Limoges, Department of Pharmacology and Toxicology, University of Limoges, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale Unit\u00e9 Mixte de Recherche 850, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Herbreteau","sequence":"additional","affiliation":[{"name":"University of Tours, Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Neuroradiology, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Tours), Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Le Touze","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Pediatric Surgery, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Tours), Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Joly","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Pediatric Maxillofacial Surgery, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies G\u00e9n\u00e9tiques rares \u00e0 Expression Cutan\u00e9e\u2013Tours), Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"L\u00e9aut\u00e9-Labr\u00e8ze","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Hospital Sainte-Justine, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bourgoin","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Pharmacy, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gissot","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale Clinical Investigation Center 1415, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[{"name":"University of Tours, University of Nantes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, SPHERE U1246, Tours, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire Tours, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale Clinical Investigation Center 1415, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Morel","sequence":"additional","affiliation":[{"name":"University of Tours, Centre Hospitalier R\u00e9gional Universitaire Tours, Department of Pediatric Radiology, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi210047r1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies.","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"issue":"2","key":"doi210047r2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.v167.2","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"4","key":"doi210047r3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA.","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"issue":"1","key":"doi210047r4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/exd.2016.25.issue-1","article-title":"Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).","volume":"25","author":"Vahidnezhad","year":"2016","journal-title":"Exp Dermatol"},{"issue":"9","key":"doi210047r5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/gim.2016.220","article-title":"Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.","volume":"19","author":"Kuentz","year":"2017","journal-title":"Genet Med"},{"issue":"4","key":"doi210047r6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000348327","article-title":"Variable somatic TIE2 mutations in half of sporadic venous malformations.","volume":"4","author":"Soblet","year":"2013","journal-title":"Mol Syndromol"},{"issue":"17","key":"doi210047r7","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1093\/hmg\/ddt198","article-title":"Venous malformation\u2013causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.","volume":"22","author":"Uebelhoer","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"1","key":"doi210047r8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/2292550317693815","article-title":"Spontaneously resolved macrocystic lymphatic malformations: predictive variables and outcomes.","volume":"25","author":"Phang","year":"2017","journal-title":"Plast Surg (Oakv)"},{"issue":"4","key":"doi210047r9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jpedsurg.2017.05.022","article-title":"Prolonged antibiotic treatment for infected low flow vascular malformations.","volume":"53","author":"Wagner","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"8","key":"doi210047r10","first-page":"328","article-title":"Venous thrombosis and coagulation parameters in patients with pure venous malformations.","volume":"75","author":"van Es","year":"2017","journal-title":"Neth J Med"},{"issue":"1","key":"doi210047r11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jvsv.2013.09.001","article-title":"Quality of life in patients with congenital vascular malformations.","volume":"2","author":"Fahrni","year":"2014","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"doi210047r12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28036","article-title":"Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies\u2014expert opinion consensus.","volume":"67","author":"Iacobas","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"doi210047r13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.anorl.2019.02.005","article-title":"Guidelines (short version) of the French Society of Otorhinolaryngology (SFORL) on cervical lymphatic malformation in adults and children: diagnosis.","volume":"136","author":"Lerat","year":"2019","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"4","key":"doi210047r14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.ro.2019.06.004","article-title":"Diagnosis and management of extracranial vascular malformations in children: arteriovenous malformations, venous malformations, and lymphatic malformations.","volume":"54","author":"Hawkins","year":"2019","journal-title":"Semin Roentgenol"},{"issue":"1","key":"doi210047r15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jvsv.2019.09.007","article-title":"Sclerotherapy for lymphatic malformations of head and neck: systematic review and meta-analysis.","volume":"8","author":"De Maria","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"4","key":"doi210047r16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvir.2019.100631","article-title":"Common (cystic) lymphatic malformations: current knowledge and management.","volume":"22","author":"Dubois","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"issue":"6","key":"doi210047r17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.v57.6","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children.","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"doi210047r18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2340\/00015555-2300","article-title":"Efficacy and safety of mammalian target of rapamycin inhibitors in vascular anomalies: a systematic review.","volume":"96","author":"Nadal","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"doi210047r19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1399-3046.2011.01575.x","article-title":"Sirolimus in pediatric renal transplantation.","volume":"15","author":"Kasap","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"8","key":"doi210047r20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/ATVBAHA.109.185918","article-title":"Rapamycin inhibition of the Akt\/mTOR pathway blocks select stages of VEGF-A164\u2013driven angiogenesis, in part by blocking S6Kinase.","volume":"29","author":"Xue","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"doi210047r21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/JID.2015.331","article-title":"Molecular genetics of the PI3K-AKT-mTOR pathway in genodermatoses: diagnostic implications and treatment opportunities.","volume":"136","author":"Vahidnezhad","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"9","key":"doi210047r22","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","article-title":"Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.","volume":"125","author":"Boscolo","year":"2015","journal-title":"J Clin Invest"},{"issue":"12","key":"doi210047r23","first-page":"1105","article-title":"Efficacy and tolerance of sirolimus (rapamycin) for extracranial arteriovenous malformations in children and adults.","volume":"99","author":"Gabeff","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"doi210047r24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies.","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"doi210047r25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jvs.2019.06.217","article-title":"Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review.","volume":"71","author":"Freixo","year":"2020","journal-title":"J Vasc Surg"},{"issue":"1","key":"doi210047r26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13023-018-0934-z","article-title":"Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study.","volume":"13","author":"Hammer","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"doi210047r27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13063-018-2725-1","article-title":"Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.","volume":"19","author":"Maruani","year":"2018","journal-title":"Trials"},{"issue":"6","key":"doi210047r28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0895-4356(00)00357-7","article-title":"The randomized placebo-phase design for clinical trials.","volume":"54","author":"Feldman","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"doi210047r29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/sim.v38.1","article-title":"Improving the efficiency of individually randomized clinical trials by staggering the introduction of the intervention.","volume":"38","author":"Hooper","year":"2019","journal-title":"Stat Med"},{"issue":"3","key":"doi210047r30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/ced.1994.19.issue-3","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use.","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"doi210047r31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.6000\/1929-6029.2013.02.02.02","article-title":"A generalization of the \u201cLady-Tasting-Tea\u201d procedure to link qualitative and quantitative approaches in psychiatric research.","volume":"2","author":"Falissard","year":"2013","journal-title":"Int J Stat Med Res"},{"issue":"2","key":"doi210047r32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bjd.16029","article-title":"Development of an international core outcome set for peripheral vascular malformations: the OVAMA Project.","volume":"178","author":"Horbach","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi210047r33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.","volume":"21","author":"Parker","year":"2019","journal-title":"Genet Med"},{"issue":"8","key":"doi210047r34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":"Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"issue":"7","key":"doi210047r35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations.","volume":"144","author":"Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"doi210047r36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2133.2009.09513.x","article-title":"Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic\/antithrombotic strategies.","volume":"162","author":"Redondo","year":"2010","journal-title":"Br J Dermatol"},{"issue":"10","key":"doi210047r37","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27896","article-title":"Effect of sirolimus on coagulopathy of slow-flow vascular malformations.","volume":"66","author":"Mack","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"doi210047r38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","article-title":"Somatic activating PIK3CA mutations cause venous malformation.","volume":"97","author":"Limaye","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"1","key":"doi210047r39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1684\/ejd.2018.3441","article-title":"Efficacy of sirolimus combined with sclerotherapy for giant cervical lymphatic macrocystic malformations: two newborn cases.","volume":"29","author":"Meurisse","year":"2019","journal-title":"Eur J Dermatol"},{"issue":"1","key":"doi210047r40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/01676830.2018.1436569","article-title":"Sirolimus-induced regression of a large orbital lymphangioma.","volume":"38","author":"Lagr\u00e8ze","year":"2019","journal-title":"Orbit"},{"issue":"2","key":"doi210047r41","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1111\/bjd.15883","article-title":"The effects of sirolimus on Kasabach-Merritt phenomenon coagulopathy.","volume":"178","author":"Boccara","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi210047r42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.TP.0000128628.31556.B1","article-title":"A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.","volume":"78","author":"Montalbano","year":"2004","journal-title":"Transplantation"},{"issue":"8","key":"doi210047r43","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1016\/j.transproceed.2010.07.083","article-title":"Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.","volume":"42","author":"S\u00e1nchez-Fructuoso","year":"2010","journal-title":"Transplant Proc"},{"issue":"4","key":"doi210047r44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy.","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2784291\/jamadermatology_maruani_2021_oi_210047_1636039113.08702.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:05:22Z","timestamp":1699459522000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2784291"}},"subtitle":["The Observational-Phase Randomized Clinical PERFORMUS Trial"],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.3459","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}